Elan Corporation, plc (NYSE: ELN) and Transition Therapeutics, Inc. (NASDAQ: TTHI) today notified clinical investigators of modifications to the Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE